IRIS - Res&Arch Institutional Research Information System - Research & Archive

IRACI, NUNZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.829
EU - Europa 1.936
AS - Asia 1.896
SA - Sud America 376
Continente sconosciuto - Info sul continente non disponibili 192
AF - Africa 47
OC - Oceania 1
Totale 7.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.750
SG - Singapore 719
UA - Ucraina 362
VN - Vietnam 320
BR - Brasile 296
IE - Irlanda 291
CN - Cina 282
RU - Federazione Russa 254
HK - Hong Kong 250
SE - Svezia 236
IT - Italia 226
GB - Regno Unito 125
DE - Germania 109
FI - Finlandia 101
FR - Francia 90
KR - Corea 66
TR - Turchia 63
IN - India 37
BE - Belgio 36
BD - Bangladesh 34
CA - Canada 31
AR - Argentina 30
MX - Messico 22
PL - Polonia 20
IQ - Iraq 18
UZ - Uzbekistan 18
NL - Olanda 17
AT - Austria 15
CO - Colombia 15
EC - Ecuador 15
ZA - Sudafrica 14
JP - Giappone 13
SA - Arabia Saudita 12
CH - Svizzera 11
ES - Italia 11
ID - Indonesia 10
PK - Pakistan 10
PH - Filippine 8
RO - Romania 7
TN - Tunisia 7
JO - Giordania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EG - Egitto 5
NP - Nepal 5
PY - Paraguay 5
VE - Venezuela 5
AL - Albania 4
CI - Costa d'Avorio 4
EU - Europa 4
JM - Giamaica 4
NI - Nicaragua 4
PA - Panama 4
PE - Perù 4
DO - Repubblica Dominicana 3
KE - Kenya 3
PS - Palestinian Territory 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GD - Grenada 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LV - Lettonia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CY - Cipro 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
Totale 7.088
Salva come PNG Salva come JPEG
Città #
Singapore 508
Chandler 349
Dublin 289
Hong Kong 244
Dong Ket 211
San Jose 191
Jacksonville 190
San Mateo 180
Ashburn 167
Santa Clara 113
Perugia 105
Boardman 98
Moscow 92
Medford 77
Princeton 76
Beijing 72
Seoul 66
Andover 65
Fremont 64
Lauterbourg 64
The Dalles 62
Wilmington 54
Dearborn 52
Ann Arbor 48
Izmir 41
São Paulo 41
Ho Chi Minh City 39
Los Angeles 38
New York 36
Altamura 35
Brussels 35
Piscataway 33
Lawrence 30
Hanoi 27
Norwalk 23
Saint Petersburg 23
Helsinki 20
West Jordan 20
Orem 17
Des Moines 15
Warsaw 15
Munich 14
Hefei 13
San Giustino 13
Tokyo 13
Brooklyn 12
Dallas 12
Philadelphia 12
Atlanta 11
Chicago 11
Phoenix 11
Montreal 10
Redmond 10
Brasília 9
Buffalo 9
Falls Church 9
Houston 9
Johannesburg 9
Nanjing 9
Rome 9
Tashkent 9
Toronto 9
Chennai 8
Denver 8
London 8
Manchester 8
Recife 8
Shanghai 8
Stockholm 8
Amsterdam 7
Auburn Hills 7
Rio de Janeiro 7
San Francisco 7
Simi Valley 7
Belo Horizonte 6
Charlotte 6
Poplar 6
Redwood City 6
San Diego 6
Tunis 6
Zhengzhou 6
Amman 5
Ankara 5
Bogotá 5
Buenos Aires 5
Columbus 5
Den Haag 5
Guangzhou 5
Istanbul 5
Jeddah 5
Jinan 5
Lappeenranta 5
Mexico City 5
Milan 5
Ribeirão Preto 5
Salvador 5
San Paolo di Civitate 5
Spoleto 5
Teresina 5
Turku 5
Totale 4.376
Salva come PNG Salva come JPEG
Nome #
1,3-DIIDRO-BENZIMIDAZOLONI ANALOGHI: PROGETTAZIONE, SINTESI E SAR DI NUOVI INIBITORI NON-NUCLEOSIDICI DELL’RT 336
1,3-Diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 323
beta-CYCLODEXTRIN HINDERS PLGA PLASTICIZATION DURING MICROPARTICLE MANUFACTURING 192
Prion protein ligands as therapeutic agents for neurodegenerative disorders 146
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 136
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 136
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 132
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 124
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 118
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 117
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 115
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 112
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 111
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 111
Diselenides and benzisoselenazolones as antiproliferative agents and glutathione-S-transferase inhibitors 111
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 111
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 110
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 110
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 109
Binding Mode Prediction of Strand Transfer HIV-1 Integrase Inhibitors Using Tn5 Transposase as a Plausible Surrogate Model for HIV-1 Integrase 108
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 108
Design and synthesis of NR2B Subtype-Selective Antagonist 105
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. 105
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 104
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 101
DECODING THE FUNCTION OF THE N-TERMINAL TAIL OF THE CELLULAR PRION PROTEIN TO INSPIRE NOVEL THERAPEUTIC AVENUES FOR NEURODEGENERATIVE DISEASES 99
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non–Nucleoside reverse Transcriptase Inhibitors 98
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 97
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 96
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 96
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 95
Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 93
Nuovi antagonisti non-competitivi del recettore NMDA/NR2B:design and sintesi 93
Exploration of the binding mode of HIV-1 integrase strand transfer inhibitors through different computational approaches. 89
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 88
Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin. 85
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 84
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 83
Nuovi chemotipi di inibitori dell'HCV NS5B polimerasi 82
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 82
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 82
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series. 81
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 80
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 78
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 78
Nuovo modello farmacoforico per inibitori dell’Integrasi dell’HIV-1: ottimizzazione della potenza di composti a struttura 1H-benzilindolica 77
Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’ HIV-1 Mediante Tecniche di Virtual screening. 77
Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication 77
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 74
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 74
New chemotypes to fight HCV infection: discovery of selective inhibitors of HCV replication with pyrazolobenzothiazine scaffold 73
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 72
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 72
Tn5 Transposase as a useful platform to simulate HIV-1 Integrase inhibitor binding mode 71
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 69
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 69
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 69
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 69
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 69
Pharmacological agents targeting the cellular prion protein 69
Docking studies on a new HIV integrase–Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 69
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 67
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors. 67
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 66
Studi Computazionali per l’Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’HIV- 65
Rational design, synthesis and SAR of 1,3-dihydro- benzimidazolone analogues as new anti-HIV agents 65
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. 65
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 64
NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors 61
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 60
NCp7: Targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders 60
Pharmacophore Modeling, Docking Experiments And Discovery Of New HIV-1 NNRTIs. 58
Progettazione, sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 55
Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. 55
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 53
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. 53
L-arginine improves solubility and anti sars-cov-2 mpro activity of rutin but not the antiviral activity in cells 50
Sperm insulin-like growth factor 2 protein levels: implications for early embryo development 13
Totale 7.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022557 0 0 12 37 47 7 5 231 27 15 88 88
2022/2023989 82 141 15 91 82 109 0 56 356 2 33 22
2023/2024481 36 62 23 11 5 8 73 35 63 29 68 68
2024/2025984 2 104 27 107 99 12 76 25 197 98 159 78
2025/20262.094 160 177 106 303 228 195 307 102 231 192 68 25
2026/2027188 58 68 62 0 0 0 0 0 0 0 0 0
Totale 7.277